how were glp 1 agonists discovered Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions Timeline of critical milestones in
Description
Waiting for FDA approval The most conservative approach is simply waiting
Average weight loss in studies is helpful for understanding trends, but individuals vary
While extensive data reassure their use, more trials are needed, particularly for populations like children, older adults, and those with severe illness
The drug is quickly eliminated in the body without accumulation
If a patient were to just take the medication without any kind of lifestyle or behavior change, they could expect to lose between 15% and 20% of their body weight, depending on the specific GLP-1 they're taking
